abrdn plc Raises Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

abrdn plc increased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 40.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 111,494 shares of the medical instruments supplier’s stock after purchasing an additional 31,852 shares during the quarter. abrdn plc owned approximately 0.05% of DENTSPLY SIRONA worth $3,968,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the company. CWM LLC lifted its stake in shares of DENTSPLY SIRONA by 85.5% during the 3rd quarter. CWM LLC now owns 4,379 shares of the medical instruments supplier’s stock worth $150,000 after purchasing an additional 2,018 shares during the period. SG Americas Securities LLC increased its stake in DENTSPLY SIRONA by 45.3% in the third quarter. SG Americas Securities LLC now owns 28,389 shares of the medical instruments supplier’s stock valued at $970,000 after purchasing an additional 8,854 shares during the last quarter. Exchange Traded Concepts LLC lifted its position in DENTSPLY SIRONA by 41.2% during the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock worth $51,000 after buying an additional 439 shares during the period. Czech National Bank boosted its stake in DENTSPLY SIRONA by 47.1% in the 3rd quarter. Czech National Bank now owns 37,003 shares of the medical instruments supplier’s stock worth $1,264,000 after buying an additional 11,849 shares during the last quarter. Finally, Asset Management One Co. Ltd. grew its holdings in DENTSPLY SIRONA by 5.0% in the 3rd quarter. Asset Management One Co. Ltd. now owns 89,835 shares of the medical instruments supplier’s stock valued at $3,069,000 after buying an additional 4,294 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Up 0.7 %

Shares of XRAY opened at $30.57 on Monday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.95 and a current ratio of 1.38. DENTSPLY SIRONA Inc. has a 12 month low of $26.27 and a 12 month high of $43.24. The stock’s 50-day moving average is $32.53 and its two-hundred day moving average is $32.78.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, topping the consensus estimate of $0.43 by $0.01. The firm had revenue of $1.01 billion for the quarter, compared to analyst estimates of $972.61 million. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. DENTSPLY SIRONA’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.46 EPS. On average, research analysts anticipate that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were paid a dividend of $0.16 per share. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 annualized dividend and a yield of 2.09%. DENTSPLY SIRONA’s payout ratio is -103.22%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Needham & Company LLC reissued a “buy” rating and issued a $42.00 target price on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. Barrington Research reissued an “outperform” rating and set a $41.00 price objective on shares of DENTSPLY SIRONA in a research note on Thursday, April 18th. SVB Leerink started coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They issued an “outperform” rating and a $42.00 target price on the stock. Leerink Partnrs reissued an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Finally, StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, January 19th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Moderate Buy” and an average price target of $39.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.